Works by Pant, Shubham

Results: 69

A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02383-5
By:
- Chan, Stephen L.;
- Schuler, Martin;
- Kang, Yoon-Koo;
- Yen, Chia-Jui;
- Edeline, Julien;
- Choo, Su Pin;
- Lin, Chia-Chi;
- Okusaka, Takuji;
- Weiss, Karl-Heinz;
- Macarulla, Teresa;
- Cattan, Stéphane;
- Blanc, Jean-Frederic;
- Lee, Kyung-Hun;
- Maur, Michela;
- Pant, Shubham;
- Kudo, Masatoshi;
- Assenat, Eric;
- Zhu, Andrew X.;
- Yau, Thomas;
- Lim, Ho Yeong
Publication type:
Article
A Phase II Study of the c-Met Inhibitor Tivantinib in Combination with FOLFOX for the Treatment of Patients with Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction, or Stomach.
Published in:
2017
By:
- Pant, Shubham;
- Patel, Manish;
- Kurkjian, Carla;
- Hemphill, Brian;
- Flores, Maria;
- Thompson, Dana;
- Bendell, Johanna
Publication type:
journal article
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors.
Published in:
2015
By:
- Bendell, Johanna C.;
- Jones, Suzanne F.;
- Hart, Lowell;
- Pant, Shubham;
- Moyhuddin, Adil;
- Lane, Cassie M.;
- Earwood, Chris;
- Murphy, Patrick;
- Patton, Jeffrey;
- Penley, William C.;
- Thompson, Dana;
- Infante, Jeffrey R.
Publication type:
journal article
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
Published in:
British Journal of Cancer, 2024, v. 130, n. 3, p. 476, doi. 10.1038/s41416-023-02534-1
By:
- Cecchini, Michael;
- Cleary, James M.;
- Shyr, Yu;
- Chao, Joseph;
- Uboha, Nataliya;
- Cho, May;
- Shields, Anthony;
- Pant, Shubham;
- Goff, Laura;
- Spencer, Kristen;
- Kim, Edward;
- Stein, Stacey;
- Kortmansky, Jeremy S.;
- Canosa, Sandra;
- Sklar, Jeffrey;
- Swisher, Elizabeth M.;
- Radke, Marc;
- Ivy, Percy;
- Boerner, Scott;
- Durecki, Diane E.
Publication type:
Article
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
Published in:
2020
By:
- Voss, Martin H.;
- Gordon, Michael S.;
- Mita, Monica;
- Rini, Brian;
- Makker, Vicky;
- Macarulla, Teresa;
- Smith, David C.;
- Cervantes, Andrés;
- Puzanov, Igor;
- Pili, Roberto;
- Wang, Ding;
- Jalal, Shadia;
- Pant, Shubham;
- Patel, Manish R.;
- Neuwirth, Rachel l.;
- Enke, Aaron;
- Shou, Yaping;
- Sedarati, Farhad;
- Faller, Douglas V.;
- Burris III, Howard A.
Publication type:
journal article
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.
Published in:
2018
By:
- Sen, Shiraj;
- Kato, Shumei;
- Agarwal, Rishi;
- Piha-Paul, Sarina;
- Hess, Kenneth;
- Karp, Daniel;
- Janku, Filip;
- Fu, Siqing;
- Naing, Aung;
- Pant, Shubham;
- Falchook, Gerald;
- Tang, Chad;
- Wu, Xifeng;
- Ye, Yuanqing;
- Tsimberidou, Apostolia;
- Subbiah, Vivek;
- Kurzrock, Razelle;
- Byers, Lauren;
- Westin, Shannon;
- Lim, JoAnn
Publication type:
journal article
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.
Published in:
NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00505-0
By:
- Yousef, Abdelrahman;
- Yousef, Mahmoud;
- Chowdhury, Saikat;
- Abdilleh, Kawther;
- Knafl, Mark;
- Edelkamp, Paul;
- Alfaro-Munoz, Kristin;
- Chacko, Ray;
- Peterson, Jennifer;
- Smaglo, Brandon G.;
- Wolff, Robert A.;
- Pant, Shubham;
- Lee, Michael S.;
- Willis, Jason;
- Overman, Michael;
- Doss, Sudheer;
- Matrisian, Lynn;
- Hurd, Mark W.;
- Snyder, Rebecca;
- Katz, Matthew H. G.
Publication type:
Article
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.
Published in:
NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00505-0
By:
- Yousef, Abdelrahman;
- Yousef, Mahmoud;
- Chowdhury, Saikat;
- Abdilleh, Kawther;
- Knafl, Mark;
- Edelkamp, Paul;
- Alfaro-Munoz, Kristin;
- Chacko, Ray;
- Peterson, Jennifer;
- Smaglo, Brandon G.;
- Wolff, Robert A.;
- Pant, Shubham;
- Lee, Michael S.;
- Willis, Jason;
- Overman, Michael;
- Doss, Sudheer;
- Matrisian, Lynn;
- Hurd, Mark W.;
- Snyder, Rebecca;
- Katz, Matthew H. G.
Publication type:
Article
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies.
Published in:
NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00369-w
By:
- Alhalabi, Omar;
- Groisberg, Roman;
- Zinner, Ralph;
- Hahn, Andrew W.;
- Naing, Aung;
- Zhang, Shizhen;
- Tsimberidou, Apostolia M.;
- Rodon, Jordi;
- Fu, Siqing;
- Yap, Timothy A.;
- Hong, David S.;
- Sun, Ming;
- Jiang, Yunfang;
- Pant, Shubham;
- Shah, Amishi Y.;
- Zurita, Amado;
- Tannir, Nizar M.;
- Vikram, Raghunandan;
- Roszik, Jason;
- Meric-Bernstam, Funda
Publication type:
Article
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients.
Published in:
Cancer Medicine, 2021, v. 10, n. 15, p. 5041, doi. 10.1002/cam4.3870
By:
- Mohindroo, Chirayu;
- Hasanov, Merve;
- Rogers, Jane E.;
- Dong, Wenli;
- Prakash, Laura R.;
- Baydogan, Seyda;
- Mizrahi, Jonathan D.;
- Overman, Michael J.;
- Varadhachary, Gauri R.;
- Wolff, Robert A.;
- Javle, Milind M.;
- Fogelman, David R.;
- Lotze, Michael T.;
- Kim, Michael P.;
- Katz, Matthew H.G.;
- Pant, Shubham;
- Tzeng, Ching‐Wei D.;
- McAllister, Florencia
Publication type:
Article
Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma.
Published in:
Cancer Medicine, 2020, v. 9, n. 15, p. 5406, doi. 10.1002/cam4.3229
By:
- Rogers, Jane E.;
- Mizrahi, Jonathan D.;
- Xiao, Lianchun;
- Mohindroo, Chirayu;
- Shroff, Rachna T.;
- Wolff, Robert;
- Varadhachary, Gauri R.;
- Javle, Milind M.;
- Overman, Michael;
- Fogelman, David R.;
- Raghav, Kanwal P. S.;
- Pant, Shubham;
- McAllister, Florencia
Publication type:
Article
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.
Published in:
2020
By:
- Perri, Giampaolo;
- Prakash, Laura;
- Qiao, Wei;
- Varadhachary, Gauri R.;
- Wolff, Robert;
- Fogelman, David;
- Overman, Michael;
- Pant, Shubham;
- Javle, Milind;
- Koay, Eugene J.;
- Herman, Joseph;
- Kim, Michael;
- Ikoma, Naruhiko;
- Tzeng, Ching-Wei;
- Lee, Jeffrey E.;
- Katz, Matthew H. G.
Publication type:
journal article
Pancreatic GIST in a Patient with Limited Stage Small Cell Lung Cancer: A Case Report and Review of Published Cases.
Published in:
Case Reports in Oncological Medicine, 2016, p. 1, doi. 10.1155/2016/9604982
By:
- Phan, Minh;
- Jones, Shari;
- Jenkins, Justin;
- Pant, Shubham;
- Khawandanah, Mohamad
Publication type:
Article
A Review of PARP Inhibitors in Clinical Development.
Published in:
Journal of Hematology Oncology Pharmacy, 2012, v. 2, n. 1, p. 18
By:
- Hopps, Sarah A.;
- Kurkjian, Carla D.;
- Pant, Shubham
Publication type:
Article
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia.
Published in:
British Journal of Haematology, 2010, v. 148, n. 4, p. 623, doi. 10.1111/j.1365-2141.2009.07947.x
By:
- Pant, Shubham;
- Hamadani, Mehdi;
- Dodds, Anthony J.;
- Szer, Jeffrey;
- Crilley, Pamela A.;
- Stevenson, Dustin;
- Phillips, Gary;
- Elder, Patrick;
- Nivison-Smith, Ian;
- Avalos, Belinda R.;
- Penza, Sam;
- Topolsky, David;
- Sobecks, Ronald;
- Kalaycio, Matt;
- Bolwell, Brian J.;
- Copelan, Edward A.
Publication type:
Article
Biological big-data sources, problems of storage, computational issues, and applications: a comprehensive review.
Published in:
Knowledge & Information Systems, 2024, v. 66, n. 6, p. 3159, doi. 10.1007/s10115-023-02049-4
By:
- Chaudhari, Jyoti Kant;
- Pant, Shubham;
- Jha, Richa;
- Pathak, Rajesh Kumar;
- Singh, Dev Bukhsh
Publication type:
Article
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.
Published in:
Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 2, p. 107, doi. 10.1007/s00280-023-04545-4
By:
- Piha-Paul, Sarina A.;
- Tseng, Chieh;
- Tran, Hai T.;
- Gao, Meng;
- Karp, Daniel D.;
- Subbiah, Vivek;
- Tsimberidou, Apostolia Maria;
- Kawedia, Jitesh D.;
- Fu, Siqing;
- Pant, Shubham;
- Yap, Timothy A.;
- Morris, Van K.;
- Kee, Bryan K.;
- Blum Murphy, Mariela;
- Lim, JoAnn;
- Meric-Bernstam, Funda
Publication type:
Article
Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies.
Published in:
Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 2, p. 73, doi. 10.36401/JIPO-23-16
By:
- Ahmed, Jibran;
- Stephen, Bettzy;
- Yali Yang;
- Kwiatkowski, Evan;
- Ejezie, Chinenye Lynette;
- Pant, Shubham
Publication type:
Article
Image of the month. Extramedullary plasmacytoma.
Published in:
2013
By:
- Landmann, Alessandra;
- Makipour, J John;
- Morgan, Ashley;
- Postier, Russell;
- Pant, Shubham;
- Liu, Cheng;
- Anderson, Justin
Publication type:
journal article
Image of the Month.
Published in:
JAMA Surgery, 2013, v. 148, n. 1, p. 101, doi. 10.1001/jamasurgery.2013.412a
By:
- Landmann, Alessandra;
- Makipour, J. John;
- Morgan, Ashley;
- Postier, Russell;
- Pant, Shubham;
- Cheng Liu;
- Anderson, Justin
Publication type:
Article
Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study.
Published in:
2019
By:
- George, Goldy C;
- Iwuanyanwu, Eucharia C;
- Buford, Adrianna S;
- Piha-Paul, Sarina A;
- Subbiah, Vivek;
- Fu, Siqing;
- Karp, Daniel D;
- Pant, Shubham;
- Hinojosa, Christina O;
- Hess, Kenneth R;
- Cleeland, Charles S;
- Bernstam, Elmer V;
- Meric-Bernstam, Funda;
- Hong, David S
Publication type:
journal article
Doublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor Cells.
Published in:
PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118933
By:
- Qu, Dongfeng;
- Johnson, Jeremy;
- Chandrakesan, Parthasarathy;
- Weygant, Nathaniel;
- May, Randal;
- Aiello, Nicole;
- Rhim, Andrew;
- Zhao, Lichao;
- Zheng, Wei;
- Lightfoot, Stanley;
- Pant, Shubham;
- Irvan, Jeremy;
- Postier, Russell;
- Hocker, James;
- Hanas, Jay S.;
- Ali, Naushad;
- Sureban, Sripathi M.;
- An, Guangyu;
- Schlosser, Michael J.;
- Stanger, Ben
Publication type:
Article
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib.
Published in:
Journal of Clinical Pharmacology, 2015, v. 55, n. 4, p. 392, doi. 10.1002/jcph.437
By:
- Suttle, A. Benjamin;
- Grossmann, Kenneth F.;
- Ouellet, Daniele;
- Richards‐Peterson, Lauren E.;
- Aktan, Gursel;
- Gordon, Michael S.;
- LoRusso, Patricia M.;
- Infante, Jeffrey R.;
- Sharma, Sunil;
- Kendra, Kari;
- Patel, Manish;
- Pant, Shubham;
- Arkenau, Hendrik‐Tobias;
- Middleton, Mark R.;
- Blackman, Samuel C.;
- Botbyl, Jeff;
- Carson, Stanley W.
Publication type:
Article
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors.
Published in:
Cancer (0008543X), 2015, v. 121, n. 7, p. 1056, doi. 10.1002/cncr.29155
By:
- Bendell, Johanna C.;
- Patel, Manish R.;
- Infante, Jeffrey R.;
- Kurkjian, Carla D.;
- Jones, Suzanne F.;
- Pant, Shubham;
- Burris, Howard A.;
- Moreno, Ofir;
- Esquibel, Vanessa;
- Levin, Wendy;
- Moore, Kathleen N.
Publication type:
Article
Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab.
Published in:
Cancer (0008543X), 2014, v. 120, n. 12, p. 1780, doi. 10.1002/cncr.28648
By:
- Pant, Shubham;
- Martin, Ludmila K.;
- Geyer, Susan;
- Wei, Lai;
- Van Loon, Katherine;
- Sommovilla, Nilli;
- Zalupski, Mark;
- Iyer, Renuka;
- Fogelman, David;
- Ko, Andrew H.;
- Bekaii‐Saab, Tanios
Publication type:
Article
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12669-5
By:
- Yao, Shuyang;
- Meric-Bernstam, Funda;
- Hong, David;
- Janku, Filip;
- Naing, Aung;
- Piha-Paul, Sarina Anne;
- Tsimberidou, Apostolia Maria;
- Karp, Daniel;
- Subbiah, Vivek;
- Yap, Timothy Anthony;
- Ahnert, Jordi Rodon;
- Pant, Shubham;
- Dumbrava, Ecaterina E Ileana;
- Wathoo, Chetna;
- Campbell, Erick;
- Yu, Lihou;
- Yamamura, Yuko;
- Fu, Siqing
Publication type:
Article
Cetuximab hypersensitivity infusion reactions: Incidence and risk factors*.
Published in:
Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 222, doi. 10.1177/1078155212462440
By:
- Hopps, Sarah;
- Medina, Patrick;
- Pant, Shubham;
- Webb, Ryan;
- Moorman, Meredith;
- Borders, Emily
Publication type:
Article
Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.
Published in:
Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 261, doi. 10.1177/1078155212459285
By:
- Cherry, Mohamad A;
- Bhardwaj, Himanshu;
- Hopps, Sarah;
- Srour, Samer;
- Pant, Shubham
Publication type:
Article
Starting at the Front Line in Metastatic Pancreatic Cancers: As New Options Emerge, How Do You Select and Sequence?
Published in:
Oncology (08909091), 2024, v. 38, n. 9, p. 352
By:
- Wainberg, Zev A.;
- Bekaii-Saab, Tanios;
- O'Reilly, Eileen;
- Pant, Shubham
Publication type:
Article
Barriers to Pancreatic Cancer Clinical Trials Enrollment.
Published in:
Oncology (08909091), 2021, v. 35, n. 1, p. 8
By:
- Lee, Michael S.;
- Pant, Shubham
Publication type:
Article
Prevalence of metabolic syndrome in sickle cell disease patients: A cross‐sectional study at a tertiary hospital in Nepal.
Published in:
EJHaem, 2024, v. 5, n. 5, p. 913, doi. 10.1002/jha2.989
By:
- Khadayat, Ramesh;
- Bishwakarma, Mukesh;
- Pant, Shubham;
- Bhatta, Om Prakash;
- Bista, Pariwesh Raj;
- Kamar, Sher Bahadur
Publication type:
Article
Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer: sitravatinib in advanced RCC and CRPC: Pant et al.
Published in:
Investigational New Drugs, 2024, v. 42, n. 5, p. 547, doi. 10.1007/s10637-024-01465-9
By:
- Pant, Shubham;
- Cho, Byoung Chul;
- Kyriakopoulos, Christos E.;
- Spira, Alexander;
- Tannir, Nizar;
- Werner, Theresa L.;
- Yan, Xiaohong;
- Neuteboom, Saskia;
- Chao, Richard;
- Goel, Sanjay
Publication type:
Article
Phase 1 study of the safety, pharmacokinetics, and preliminary efficacy of CA102N as monotherapy and in combination with trifluridine-tipiracil in patients with locally advanced or metastatic solid tumors.
Published in:
Investigational New Drugs, 2023, v. 41, n. 1, p. 25, doi. 10.1007/s10637-022-01308-5
By:
- Pant, Shubham;
- Dragovich, Tomislav;
- Lieu, Christopher;
- Jimeno, Antonio;
- Kundranda, Madappa;
- Menter, David;
- Tchaparian, Eskouhie;
- Chen, Yuchih C.;
- Kopetz, Scott
Publication type:
Article
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2022, v. 40, n. 5, p. 990, doi. 10.1007/s10637-022-01274-y
By:
- Bauer, Todd;
- Cho, Byong Chul;
- Heist, Rebecca;
- Bazhenova, Lyudmila;
- Werner, Theresa;
- Goel, Sanjay;
- Kim, Dong-Wan;
- Adkins, Douglas;
- Carvajal, Richard D.;
- Alva, Ajjai;
- Eaton, Keith;
- Wang, Judy;
- Liu, Yong;
- Yan, Xiaohong;
- Christensen, Jamie;
- Neuteboom, Saskia;
- Chao, Richard;
- Pant, Shubham
Publication type:
Article
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Published in:
2022
By:
- Thein, Kyaw Zin;
- Piha-Paul, Sarina A.;
- Tsimberidou, Apostolia;
- Karp, Daniel D.;
- Janku, Filip;
- Zarifa, Abdulrazzak;
- Shah, Jatin;
- Milton, Denái R.;
- Bean, Stacie;
- McQuinn, Lacey;
- Gong, Jing;
- Colen, Rivka;
- Carter, Brett W.;
- Subbiah, Vivek;
- Ogbonna, Deby C.;
- Pant, Shubham;
- Meric-Bernstam, Funda;
- Naing, Aung
Publication type:
Correction Notice
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi‐arm phase Ib study.
Published in:
Investigational New Drugs, 2021, v. 39, n. 5, p. 1357, doi. 10.1007/s10637-021-01119-0
By:
- Thein, Kyaw Zin;
- Piha-Paul, Sarina A.;
- Tsimberidou, Apostolia;
- Karp, Daniel D.;
- Janku, Filip;
- Zarifa, Abdulrazzak;
- Shah, Jatin;
- Milton, Denái R.;
- Bean, Stacie;
- McQuinn, Lacey;
- Gong, Jing;
- Colen, Rivka;
- Carter, Brett W.;
- Subbiah, Vivek;
- Ogbonna, Deby C.;
- Pant, Shubham;
- Meric-Bernstam, Funda;
- Naing, Aung
Publication type:
Article
A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors.
Published in:
Investigational New Drugs, 2021, v. 39, n. 4, p. 1089, doi. 10.1007/s10637-021-01094-6
By:
- Azaro, Analia;
- Massard, Christophe;
- Tap, William D.;
- Cassier, Philippe A.;
- Merchan, Jaime;
- Italiano, Antoine;
- Anderson, Bailey;
- Yuen, Eunice;
- Yu, Danni;
- Oakley III, Gerard;
- Benhadji, Karim A.;
- Pant, Shubham
Publication type:
Article
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).
Published in:
Investigational New Drugs, 2021, v. 39, n. 1, p. 182, doi. 10.1007/s10637-020-01000-6
By:
- Hecht, J. Randolph;
- Papadopoulos, Kyriakos P.;
- Falchook, Gerald S.;
- Patel, Manish R.;
- Infante, Jeffrey R.;
- Aljumaily, Raid;
- Wong, Deborah J.;
- Autio, Karen A.;
- Wainberg, Zev A.;
- Bauer, Todd M.;
- Javle, Milind;
- Pant, Shubham;
- Bendell, Johanna;
- Hung, Annie;
- Ratti, Navneet;
- VanVlasselaer, Peter;
- Verma, Rakesh;
- Leveque, Joseph;
- Rao, Sujata;
- Oft, Martin
Publication type:
Article
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.
Published in:
Investigational New Drugs, 2018, v. 36, n. 6, p. 1016, doi. 10.1007/s10637-018-0591-z
By:
- Aghajanian, Carol;
- Bell-McGuinn, Katherine M.;
- Burris, Howard A.;
- Siu, Lillian L.;
- Stayner, Lee-Ann;
- Wheler, Jennifer J.;
- Hong, David S.;
- Kurkjian, Carla;
- Pant, Shubham;
- Santiago-Walker, Ademi;
- Gauvin, Jennifer L.;
- Antal, Joyce M.;
- Opalinska, Joanna B.;
- Morris, Shannon R.;
- Infante, Jeffrey R.
Publication type:
Article
Effects of rifampin, itraconazole and esomeprazole on the pharmacokinetics of alisertib, an investigational aurora a kinase inhibitor in patients with advanced malignancies.
Published in:
Investigational New Drugs, 2018, v. 36, n. 2, p. 248, doi. 10.1007/s10637-017-0499-z
By:
- Xiaofei Zhou;
- Pant, Shubham;
- Nemunaitis, John;
- Lockhart, A. Craig;
- Falchook, Gerald;
- Bauer, Todd M.;
- Patel, Manish;
- Sarantopoulos, John;
- Bargfrede, Michael;
- Muehler, Andreas;
- Rangachari, Lakshmi;
- Bin Zhang;
- Venkatakrishnan, Karthik
Publication type:
Article
Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies.
Published in:
Investigational New Drugs, 2018, v. 36, n. 2, p. 240, doi. 10.1007/s10637-017-0498-0
By:
- Xiaofei Zhou;
- Nemunaitis, John;
- Pant, Shubham;
- Bauer, Todd M.;
- Patel, Manish;
- Sarantopoulos, John;
- Lockhart, A. Craig;
- Goodman, Daniel;
- Huebner, Dirk;
- Mould, Diane R.;
- Venkatakrishnan, Karthik
Publication type:
Article
A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2014, v. 32, n. 1, p. 87, doi. 10.1007/s10637-013-9949-4
By:
- Pant, Shubham;
- Burris, Howard;
- Moore, Kathleen;
- Bendell, Johanna;
- Kurkjian, Carla;
- Jones, Suzanne;
- Moreno, Ofir;
- Kuhn, John;
- McMeekin, Scott;
- Infante, Jeffrey
Publication type:
Article
Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors.
Published in:
2016
By:
- Sarantopoulos, John;
- Goel, Sanjay;
- Chung, Vincent;
- Munster, Pamela;
- Pant, Shubham;
- Patel, Manish;
- Infante, Jeffrey;
- Tawbi, Hussein;
- Becerra, Carlos;
- Bruce, Justine;
- Kabbinavar, Fairooz;
- Lockhart, A.;
- Tan, Eugene;
- Yang, Shu;
- Carlson, Gary;
- Scott, Jeffrey;
- Sharma, Sunil;
- Patel, Manish R;
- Lockhart, A Craig;
- Scott, Jeffrey W
Publication type:
journal article
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors.
Published in:
2016
By:
- Bendell, Johanna;
- Patel, Manish;
- Yoshida, Kenichiro;
- Seraj, Jabed;
- Weaver, Racquel;
- Lemech, Charlotte;
- Todaro, Thomas;
- Pant, Shubham;
- Arkenau, Hendrik-Tobias;
- Bendell, Johanna C;
- Patel, Manish R;
- Todaro, Thomas G
Publication type:
journal article
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.
Published in:
Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 49, doi. 10.1007/s00280-012-1887-x
By:
- Lustberg, Maryam;
- Pant, Shubham;
- Ruppert, Amy;
- Shen, Tong;
- Wei, Yong;
- Chen, Ling;
- Brenner, Lisa;
- Shiels, Donna;
- Jensen, Rhonda;
- Berger, Michael;
- Mrozek, Ewa;
- Ramaswamy, Bhuvaneswari;
- Grever, Michael;
- Au, Jessie;
- Wientjes, M.;
- Shapiro, Charles
Publication type:
Article
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition.
Published in:
NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00240-w
By:
- Coleman, Niamh;
- Subbiah, Vivek;
- Pant, Shubham;
- Patel, Keyur;
- Roy-Chowdhuri, Sinchita;
- Yedururi, Sireesha;
- Johnson, Amber;
- Yap, Timothy A.;
- Rodon, Jordi;
- Shaw, Kenna;
- Meric-Bernstam, Funda
Publication type:
Article
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.
Published in:
Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae182
By:
- Yousef, Mahmoud;
- Hurd, Mark W;
- Yousef, Abdelrahman;
- Ludmir, Ethan B;
- Pillai, Ashwathy B;
- Peterson, Jennifer;
- Koay, Eugene J;
- Albarouki, Sali;
- Tzeng, Ching-Wei;
- Snyder, Rebecca;
- Katz, Matthew H G;
- Wang, Huamin;
- Overman, Michael J;
- Maitra, Anirban;
- Pant, Shubham;
- Smaglo, Brandon G;
- Wolff, Robert A;
- Yao, James;
- Shen, John P;
- Zhao, Dan
Publication type:
Article
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
Published in:
Oncologist, 2024, v. 29, n. 6, p. 493, doi. 10.1093/oncolo/oyae011
By:
- Ngoi, Natalie Y L;
- Tang, Tin-Yun;
- Gaspar, Catia F;
- Pavlick, Dean C;
- Buchold, Gregory M;
- Scholefield, Emma L;
- Parimi, Vamsi;
- Huang, Richard S P;
- Janovitz, Tyler;
- Danziger, Natalie;
- Levy, Mia A;
- Pant, Shubham;
- Armas, Anaemy Danner De;
- Kumpula, David;
- Ross, Jeffrey S;
- Javle, Milind;
- Ahnert, Jordi Rodon
Publication type:
Article
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
Published in:
Oncologist, 2023, v. 28, n. 12, p. 1100, doi. 10.1093/oncolo/oyad158
By:
- Nelson, Blessie Elizabeth;
- Tsimberidou, Apostolia M;
- Fu, Xueyao;
- Fu, Siqing;
- Subbiah, Vivek;
- Sood, Anil K;
- Rodon, Jordi;
- Karp, Daniel D;
- Blumenschein, George;
- Kopetz, Scott;
- Pant, Shubham;
- Piha-Paul, Sarina A
Publication type:
Article
Patient‐Reported Out‐of‐Pocket Costs and Financial Toxicity During Early‐Phase Oncology Clinical Trials.
Published in:
Oncologist, 2021, v. 26, n. 7, p. 588, doi. 10.1002/onco.13767
By:
- Huey, Ryan W.;
- George, Goldy C.;
- Phillips, Penny;
- White, Revenda;
- Fu, Siqing;
- Janku, Filip;
- Karp, Daniel D.;
- Naing, Aung;
- Piha‐Paul, Sarina;
- Subbiah, Vivek;
- Tsimberidou, Apostolia M.;
- Pant, Shubham;
- Yap, Timothy A.;
- Rodon, Jordi;
- Meric‐Bernstam, Funda;
- Shih, Ya‐Chen Tina;
- Hong, David S.
Publication type:
Article